TTK Healthcare Limited (NSE:TTKHLTCARE)
India · Delayed Price · Currency is INR 1,341.30
-14.30 (-1.05%)
Jul 16, 2025, 3:29 PM IST
TTK Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 8,015 | 7,528 | 7,251 | 5,992 | 4,761 | Upgrade | |
Revenue Growth (YoY) | 6.47% | 3.82% | 21.00% | 25.87% | -26.28% | Upgrade |
Cost of Revenue | 3,907 | 3,560 | 3,630 | 2,912 | 2,193 | Upgrade |
Gross Profit | 4,108 | 3,968 | 3,621 | 3,080 | 2,568 | Upgrade |
Selling, General & Admin | 2,582 | 2,488 | 2,268 | 1,952 | 1,657 | Upgrade |
Other Operating Expenses | 1,174 | 1,100 | 1,034 | 907.86 | 714.85 | Upgrade |
Operating Expenses | 3,843 | 3,724 | 3,435 | 2,988 | 2,504 | Upgrade |
Operating Income | 265.27 | 244.22 | 186.81 | 92.82 | 64.36 | Upgrade |
Interest Expense | -19.49 | -19.29 | -52.39 | -32.38 | -17.11 | Upgrade |
Interest & Investment Income | 695.15 | 622.17 | 463.7 | 147.59 | 98.78 | Upgrade |
Currency Exchange Gain (Loss) | 2.11 | 2.57 | 5.62 | 3.12 | 0.29 | Upgrade |
Other Non Operating Income (Expenses) | 1.54 | -6.94 | 14 | 12.6 | 0.28 | Upgrade |
EBT Excluding Unusual Items | 944.57 | 842.73 | 617.74 | 223.75 | 146.6 | Upgrade |
Gain (Loss) on Sale of Assets | -0.31 | -0.33 | -1.38 | -0.16 | -1.19 | Upgrade |
Asset Writedown | -0.01 | -1.2 | - | -0.13 | -0.17 | Upgrade |
Other Unusual Items | 139.07 | - | - | 24.91 | 80.98 | Upgrade |
Pretax Income | 1,083 | 841.2 | 616.36 | 248.37 | 226.22 | Upgrade |
Income Tax Expense | 266.75 | 212.78 | 169.68 | 63.27 | -141.6 | Upgrade |
Earnings From Continuing Operations | 816.57 | 628.42 | 446.68 | 185.1 | 367.82 | Upgrade |
Earnings From Discontinued Operations | - | - | 5,950 | 230.78 | 96.59 | Upgrade |
Net Income | 816.57 | 628.42 | 6,397 | 415.88 | 464.41 | Upgrade |
Net Income to Common | 816.57 | 628.42 | 6,397 | 415.88 | 464.41 | Upgrade |
Net Income Growth | 29.94% | -90.18% | 1438.20% | -10.45% | 276.98% | Upgrade |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | Upgrade |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | Upgrade |
EPS (Basic) | 57.79 | 44.47 | 452.73 | 29.43 | 32.87 | Upgrade |
EPS (Diluted) | 57.79 | 44.47 | 452.73 | 29.43 | 32.87 | Upgrade |
EPS Growth | 29.95% | -90.18% | 1438.20% | -10.45% | 276.96% | Upgrade |
Free Cash Flow | -168.16 | -153.27 | -365.1 | 394.91 | 946.88 | Upgrade |
Free Cash Flow Per Share | -11.90 | -10.85 | -25.84 | 27.95 | 67.01 | Upgrade |
Dividend Per Share | 10.000 | 10.000 | 10.000 | 10.000 | 6.000 | Upgrade |
Dividend Growth | - | - | - | 66.67% | 100.00% | Upgrade |
Gross Margin | 51.26% | 52.71% | 49.94% | 51.40% | 53.94% | Upgrade |
Operating Margin | 3.31% | 3.24% | 2.58% | 1.55% | 1.35% | Upgrade |
Profit Margin | 10.19% | 8.35% | 88.22% | 6.94% | 9.75% | Upgrade |
Free Cash Flow Margin | -2.10% | -2.04% | -5.04% | 6.59% | 19.89% | Upgrade |
EBITDA | 341.73 | 367.16 | 314.38 | 217.99 | 193.72 | Upgrade |
EBITDA Margin | 4.26% | 4.88% | 4.34% | 3.64% | 4.07% | Upgrade |
D&A For EBITDA | 76.47 | 122.95 | 127.57 | 125.16 | 129.36 | Upgrade |
EBIT | 265.27 | 244.22 | 186.81 | 92.82 | 64.36 | Upgrade |
EBIT Margin | 3.31% | 3.24% | 2.58% | 1.55% | 1.35% | Upgrade |
Effective Tax Rate | 24.62% | 25.30% | 27.53% | 25.47% | - | Upgrade |
Revenue as Reported | 8,727 | 8,154 | 7,734 | 6,156 | 4,860 | Upgrade |
Advertising Expenses | 1,048 | 1,132 | 1,012 | 893.1 | 698.6 | Upgrade |
Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.